The electrostatic confinement of aquated monocationic Gd(iii) complex-molecules within the inner core of porous silica nanoparticles creates a highly efficient T1 contrast agent for magnetic resonance imaging

Contrast-agent enhanced magnetic resonance imaging (MRI) has been under continuous investigation for the conspicuous imaging of lesions and the early-stage detection of tumors. To achieve the development of a T-1-weighted contrast agent with a high relaxivity value, herein, porous silica nanoparticles that had internalized about 20 aquated cationic Gd(iii) complexes (1) of the hexadentate hydroxyethyl-appended picolinate-based ligand H(2)hbda were demonstrated. Complex 1 exhibited a longitudinal relaxivity value per mM Gd(iii) ions, r(1), of 9.05 mM(-1) s(-1) (pH 7.4, 37 degrees C, 1.41 T), which increased to 86.41 mM(-1) s(-1) because of the grafting of complex 1 in the inner core of porous silica nanospheres through electrostatic interactions between the anionic silica surface and the cationic complex 1 molecules. A further augmentation in the relaxivity value to 118.32 mM(-1) s(-1) was realized because of the interaction of the complex 1@SiO(2)NPs with serum albumin protein. The synthesized nanosystem was impervious to physiologically available anions (HPO42- and HCO31-) and also kinetically inert, as evidenced via a transmetallation experiment in the presence of Zn(ii) ions. The developed complex-incorporated nanomaterial was bio- and hemo-compatible. Cellular uptake measurements employing HeLa cells and the concentration-dependent enhancement in the brightness of in vitro phantom images, recorded under a clinical scanner at 1.5 T, demonstrated that the developed biocompatible 1@SiO2NP complex has promising diagnostic applications as a T-1-weighted MRI contrast agent.

Automated summary

A high relaxivity T-1-weighted MRI contrast agent was developed by incorporating Gd(iii) complex 1 into porous silica nanoparticles, leading to a significant increase in relaxivity value for lesion imaging and tumor detection. The nanomaterial showed potential diagnostic applications as a biocompatible contrast agent, promising early-stage tumor detection.